X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (337) 337
animals (256) 256
male (156) 156
female (143) 143
index medicus (143) 143
mice (133) 133
deoxyuridine - analogs & derivatives (118) 118
deoxyuridine - therapeutic use (108) 108
oncology (93) 93
deoxyuridine - metabolism (88) 88
adult (75) 75
middle aged (71) 71
pharmacology & pharmacy (71) 71
rats (64) 64
aged (62) 62
deoxyuridine - pharmacology (54) 54
biochemistry & molecular biology (48) 48
antiviral agents - therapeutic use (47) 47
cancer (47) 47
time factors (45) 45
deoxyuridine (43) 43
5-fluorouracil (42) 42
dose-response relationship, drug (42) 42
apoptosis (39) 39
chemotherapy (39) 39
dna - biosynthesis (39) 39
thymidine - metabolism (39) 39
cells, cultured (37) 37
antineoplastic agents - therapeutic use (35) 35
5 2' deoxyuridine (34) 34
cell line, tumor (34) 34
cells (33) 33
expression (33) 33
fluorouracil - therapeutic use (32) 32
dna (31) 31
nucleosides (31) 31
deoxyuridine - administration & dosage (30) 30
therapy (30) 30
tumor cells, cultured (30) 30
herpes simplex - drug therapy (29) 29
idoxuridine - therapeutic use (29) 29
bromodeoxyuridine - analogs & derivatives (28) 28
keratitis, dendritic - drug therapy (28) 28
neoplasms - drug therapy (28) 28
rabbits (28) 28
cell proliferation (26) 26
medicine, research & experimental (26) 26
methotrexate - therapeutic use (26) 26
radiology, nuclear medicine & medical imaging (26) 26
5-fluoro-2'-deoxyuridine (25) 25
leukemia l1210 - drug therapy (25) 25
tritium (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (24) 24
cell biology (24) 24
cell division - drug effects (24) 24
deoxyuridine - chemistry (24) 24
dna, neoplasm - biosynthesis (24) 24
in vitro techniques (24) 24
proliferation (24) 24
radiotherapy (24) 24
research (24) 24
article (23) 23
cell line (23) 23
floxuridine - therapeutic use (23) 23
simplexvirus - drug effects (23) 23
thymidylate synthase - antagonists & inhibitors (23) 23
antineoplastic agents - pharmacology (22) 22
bone marrow - metabolism (22) 22
deoxycytidine - analogs & derivatives (22) 22
in-vitro (22) 22
-5- (21) 21
5-iodo-2'-deoxyuridine (21) 21
antimetabolites, antineoplastic - therapeutic use (21) 21
care and treatment (21) 21
cell proliferation - drug effects (21) 21
neoplasm transplantation (21) 21
thymidine (21) 21
tumors (21) 21
adolescent (20) 20
bromodeoxyuridine - therapeutic use (20) 20
cell survival - drug effects (20) 20
child (20) 20
disease models, animal (20) 20
nucleotides (20) 20
medicine & public health (19) 19
pharmacology/toxicology (19) 19
treatment outcome (19) 19
analysis (18) 18
apoptosis - drug effects (18) 18
chemistry, medicinal (18) 18
herpes zoster - drug therapy (18) 18
research article (18) 18
antiviral agents - pharmacology (17) 17
idoxuridine - administration & dosage (17) 17
pharmacokinetics (17) 17
rats, sprague-dawley (17) 17
studies (17) 17
bone marrow - drug effects (16) 16
deoxyribonucleic acid--dna (16) 16
deoxyuridine - chemical synthesis (16) 16
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (529) 529
German (18) 18
Japanese (11) 11
Hungarian (4) 4
Russian (4) 4
French (3) 3
Italian (2) 2
Polish (2) 2
Bulgarian (1) 1
Croatian (1) 1
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 1/2007, Volume 44, Issue 1, pp. S1 - S26
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 2014, Volume 11, Issue 5, pp. 282 - 298
Journal Article
Drugs & Aging, ISSN 1170-229X, 2008, Volume 25, Issue 12, pp. 991 - 1006
Journal Article
Cancer Science, ISSN 1347-9032, 05/2016, Volume 107, Issue 5, pp. 659 - 665
TAS‐102, a novel oral antitumor agent, consists of trifluridine and tipiracil hydrochloride (molar ratio, 1:0.5). We investigated the effects of food on... 
pharmacokinetics | Effect of food | TAS‐102 | tipiracil hydrochloride | trifluridine | TAS-102 | Tipiracil hydrochloride | Trifluridine | Pharmacokinetics | VIVO | 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE | ANTITUMOR-ACTIVITY | CANCER | TRIAL | ONCOLOGY | FLUORINATED PYRIMIDINES | DEOXYRIBONUCLEIC ACID | THYMIDINE PHOSPHORYLASE | Neoplasms - metabolism | Thymine - pharmacokinetics | Nausea - chemically induced | Area Under Curve | Humans | Middle Aged | Pyrrolidines - adverse effects | Biological Availability | Male | Antineoplastic Agents - therapeutic use | Trifluridine - pharmacokinetics | Pyrrolidines - pharmacology | Pyrrolidines - therapeutic use | Uracil - pharmacology | Antineoplastic Agents - adverse effects | Leukopenia - chemically induced | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Thymine - pharmacology | Neutropenia - chemically induced | Trifluridine - pharmacology | Fasting | Thymine - therapeutic use | Thymine - adverse effects | Pyrrolidines - pharmacokinetics | Food-Drug Interactions | Japan | Anemia - chemically induced | Uracil - therapeutic use | Neoplasms - drug therapy | Cross-Over Studies | Trifluridine - therapeutic use | Asian Continental Ancestry Group | Uracil - adverse effects | Trifluridine - adverse effects | Aged | Neoplasms - pathology | Uracil - pharmacokinetics | Drug Combinations | Uracil - analogs & derivatives | Drugs | Complications and side effects | Care and treatment | Safety and security measures | Analysis | Colorectal cancer | Prostate cancer | Tumors | Food | Lung cancer | Metastasis | Cancer therapies | Thymus | Consent | Safety | Meals | Drug dosages | Neutropenia | Leukopenia | Hematology | Research funding | Neutrophils | Nausea | Leukocytes (neutrophilic) | Bioavailability | Patients | Studies | Rectum | Breast | Clinical medicine | Solid tumors | Prostate | Pharmaceuticals | Original
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2011, Volume 17, Issue 18, pp. 6071 - 6082
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2009, Issue 2, p. CD006866
Journal Article
Investigational New Drugs, ISSN 0167-6997, 10/2015, Volume 33, Issue 5, pp. 1068 - 1077
Journal Article
Journal Article